Pediatric Emergence Agitation: Best Practice Guideline for Certified Registered Nurse Anesthetists by Cockrell, Michael
The University of Southern Mississippi 
The Aquila Digital Community 
Doctoral Projects 
Fall 2020 
Pediatric Emergence Agitation: Best Practice Guideline for 
Certified Registered Nurse Anesthetists 
Michael Cockrell 
Follow this and additional works at: https://aquila.usm.edu/dnp_capstone 
Recommended Citation 
Cockrell, Michael, "Pediatric Emergence Agitation: Best Practice Guideline for Certified Registered Nurse 
Anesthetists" (2020). Doctoral Projects. 147. 
https://aquila.usm.edu/dnp_capstone/147 
This Dissertation/Thesis is brought to you for free and open access by The Aquila Digital Community. It has been 
accepted for inclusion in Doctoral Projects by an authorized administrator of The Aquila Digital Community. For 
more information, please contact Joshua.Cromwell@usm.edu. 
PEDIATRIC EMERGENCE AGITATION: BEST PRACTICE GUIDELINE FOR 





Michael Kaleb Cockrell 
A Doctoral Project 
Submitted to the Graduate School, 
the College of Nursing and Health Professions 
and the School of Leadership and Advanced Nursing Practice 
at The University of Southern Mississippi 
in Partial Fulfillment of the Requirements 
for the Degree of Doctor of Nursing Practice 
Approved by: 
 
Dr. Mary Jane Collins, Committee Chair 















Michael Kaleb Cockrell 
2020 







 The adverse effects of general anesthesia can vary significantly among groups of 
individuals. The pediatric population is no exception. Pediatric emergence agitation is a 
potential adverse effect observed following emergence from general anesthesia. The 
negative impacts from this adverse effect have the potential to decrease patient 
satisfaction, increased the cost of care, and increase the risk of post-operative 
complications. The exact etiology of pediatric emergence agitation remains unclear; 
however, it is thought to be multifactorial (Hoch, 2019). A targeted review of the current 
literature suggests a reduction in the incidence of pediatric emergence agitation could be 
achieved through alterations in anesthetic techniques. Currently, the literature identifies a 
gap existing between evidence-based techniques and actual anesthetic practice (Hoch, 
2019).  
 This project utilized a systemic review of current, evidence-based literature to 
develop a best-practice guideline for reducing the incidence of pediatric emergence 
agitation. The guideline and supporting literature was presented to a panel of experts in 
the field of anesthesia. Panel members were asked to review the guideline and supporting 
literature, and offer feedback. Feedback from the panel of experts indicated they were 
receptive to the content of contained in the best-practice guideline. Data from the panel of 
experts was reviewed and considered in the final draft of this guideline. The final best-
practice guideline was given to members of the panel of experts working at a hospital in 
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CHAPTER I - INTRODUCTION AND BACKGROUND 
The four pillars of general anesthesia include loss of consciousness and amnesia, 
analgesia, the abolishment of autonomic reflex responses, and muscle relaxation 
(Lerman & JÖhr, 2009). The effects of general anesthesia can vary greatly among 
different individuals. Therefore, each anesthetic intervention and technique must be 
individually tailored to meet the needs of the current patient being treated. The effects of 
general anesthesia on the pediatric population are substantially different in comparison 
to the effects seen in adults. Pediatric emergence agitation (EA) is one such effect 
routinely observed postoperatively in the pediatric setting following the administration of 
general anesthesia (Hoch, 2019). The consequences of this common complication have 
the potential to negatively impact the patient’s and their family’s perception concerning 
the quality of anesthetic care. Interventions aimed at reducing the risk of pediatric EA 
can potentially improve these negative perceptions, as well as lead to increases in patient 
satisfaction, and reduced instances of post-operative complications.  
Problem Description 
Background  
Pediatric EA is a common postoperative side effect likely to be experienced by 
many patients in the pediatric setting following the administration of general anesthesia 
for surgical interventions. According to an article by the American Association of Nurse 
Anesthetists (AANA), the postoperative effects of pediatric EA are described as “a state 
of mental confusion, agitation, hyperexcitability, crying, restlessness, and hallucinations” 
(Hoch, 2019). Risk factors previously identified to correlate with an increased risk of 
developing pediatric EA following surgery include children between the ages of 2-5 years 
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old, the child’s personality and level of preoperative anxiety, the type and length of 
surgery, use of inhalational anesthetics, rapid emergence from anesthesia, and intensity of 
postoperative pain (Hoch, 2019). Estimates concerning the incidence of PEA are 
approximated to be anywhere from 10%, to as high as 80% (Bajwa et al., 2010). 
Significance of Project 
Pediatric EA typically occurs approximately 30 minutes following surgery, and 
although considered to be a self-limiting complication, the effects can last for up to two 
days (Hoch, 2019). The risks associated with pediatric EA are typically benign in 
comparison to the more severe risks of general anesthesia such as hypoxia, cerebral 
ischemia, and/or death. However, the development of pediatric EA can lead to 
complications such as physical injury, removal or dislodgement of drains and catheters, 
and interruption of monitoring devices, all of which have the potential to adversely 
impact the patient’s health and increase the overall cost of recovery. The effects of these 
complications also diminish patient and family satisfaction, as well as their perception of 
the quality of care (Hoch, 2019). An opportunity exists for anesthesia providers to 
implement interventions aimed at reducing the risk and overall occurrence of pediatric 
EA.  
Statement of Problem 
The effects of pediatric emergence agitation have the potential to lead to 
decreased patient and family satisfaction, higher costs of care, and increased 
postoperative complications. Ultimately, the current incidence of pediatric emergence 
agitation remains elevated due to an existing gap between current evidence-based 
literature and actual clinical practice (Hoch, 2019). The goal of the project’s best-practice 
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guideline was  to develop a set of recommendations, through a systematic synthesis of 
peer-reviewed, evidence-based literature, to reduce the incidence of pediatric EA. 
Anesthetic interventions including pharmacological strategies and alterations in 
anesthetic methods, techniques, and management were examined and discussed 
throughout the entirety of this project. 
 Available Knowledge 
Patient Satisfaction 
The Centers for Medicare and Medicaid Services began the development of the 
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey 
in 2002 (Tevis et al., 2015). The HCAHPS survey is designed to motivate hospitals to 
improve quality of care, provide publicly transparent survey results, and allow consumers 
to objectively compare hospitals. Hospitals are required to collect a minimum of 300 
HCAHPS surveys each year for Inpatient Prospective Payment System. In 2005, 
Medicare reimbursement for a hospital has been linked to the hospital’s performance on 
the HCAHPS survey (Tevis et al.,, 2015). 
Inhalation Anesthetics 
Inhalation anesthetics are considered to be the mainstay of general anesthesia. In 
the United States, four inhalational anesthetics are approved for use in pediatric 
anesthesia: Desflurane, Isoflurane, Sevoflurane, and Nitrous Oxide. These anesthetic 
gases provide easy to deliver, effective, and reliable anesthesia (Lerman & JÖhr, 2009). 
Inhalational anesthetics provide a means for the practitioner to induce general anesthesia 
without intravenous (IV) access. Inhalation induction is accomplished with relative ease, 
by having the patient breathe the anesthetic gas via facemask. Inhalation induction is 
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largely the most practiced technique for inducing general anesthesia in pediatric 
populations (Lerman & JÖhr, 2009). 
Sevoflurane is the most commonly used inhalation agent for producing general 
anesthesia in the pediatric population. Sevoflurane is preferred for the induction of 
pediatric cases due to its non-pungent odor, relatively minimal irritant effect on the 
patient’s airway, and the ability to produce a rapid onset and emergence of anesthesia 
(Key et al., 2010). These qualities make Sevoflurane an ideal anesthetic gas for 
performing an inhalation induction. Mean alveolar concentration (MAC) is used to 
express the dose of inhalational anesthetic required to produce surgical anesthesia and 
muscular relaxation in 50% of patients when exposed to a noxious stimulus (Nagelhout, 
2017b). Monitoring this inhalational anesthetic for the appropriate depth of anesthesia is 
accomplished with relative ease and straightforwardness through calculated end-tidal 
percentage measurements. These calculations help the anesthetist ensure that adequate 
and safe level anesthesia is being delivered by providing real-time measurements taken at 
the end of each respiratory cycle. For adult patients, the MAC of Sevoflurane in oxygen 
is 2%. In pediatrics, the MAC requirements of Sevoflurane in oxygen can increase up to 
3% in infants from six to 12 months of age. After 12 months of age, the MAC 
requirement can be slightly reduced, but remains at a higher value compared to the MAC 
requirement of adults. (Nagelhout, 2017a). The blood-gas coefficient describes the 
proportion of anesthetic gas’s solubility in the blood (Nagelhout, 2017b). Furthermore, 
the blood-gas coefficient indicates the speed of uptake and elimination of anesthetic gas. 
Agents with lower blood-gas coefficients leave the blood quickly and spread into the 
tissues, producing a rapid onset of anesthesia. For example, Isoflurane has one of the 
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highest blood-gas coefficients (1.4) producing a slow onset and emergence, while 
Desflurane has one of the lowest (0.42) and has a very rapid onset and emergence. The 
blood-gas coefficient of Sevoflurane is 0.6, meaning that it produces a rapid induction as 
well as a relatively quick emergence (Nagelhout, 2017b). This effect can be particularly 
beneficial for many scenarios encountered in pediatrics, especially when the need to 
produce a rapid onset of anesthesia is warranted. However, the literature suggests 
increased rates of pediatric EA may occur following rapid emergence from general 
anesthesia with Sevoflurane. A recently published article examining the emergence 
delirium in children states that rapid emergence from Sevoflurane may produce a 
dissociative state in pediatric patients, resulting in altered cognition proception, 
excitement, and irritability (Locatelli et al., 2013).  
Total Intravenous Anesthesia 
Total Intravenous Anesthesia (TIVA) describes an anesthetic technique that uses 
IV medications to produce a level of surgical anesthesia comparable to that of 
inhalational techniques. Recent advancements in technology have made the use of TIVA 
more desirable for some pediatric cases. The advantages of TIVA include smooth 
emergence from general anesthesia, a reduction in the incidence of postoperative nausea 
and vomiting, and rapid onset (Lerman & JÖhr, 2009).  
TIVA is typically accomplished through the administration of one or more 
combinations of IV medications. Currently, propofol is the most common medication 
used in pediatric cases for inducing and maintaining general anesthesia (Lerman & JÖhr, 
2009). Propofol’s mechanism of action is through the enhancement of -aminobutyric 
acid (GABA) chloride channels. This agonistic effect on GABA receptors produces 
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strong sedative effects that are considered ideal for IV maintenance of general anesthesia. 
Currently, the recommended dosage for IV administration of propofol in pediatric 
patients is 1-2 milligrams (mg) per kilogram (kg) given as a bolus. Propofol has several 
advantages in various settings of anesthesia and is generally associated with a calm, 
sometimes euphoric, rapid recovery from general anesthesia (Key et al., 2010). 
Anesthetic techniques using propofol TIVA have been shown to decrease the incidence 
of pediatric EA. One study compared the quality of recovery in a group of pediatric 
patients following inhalational anesthesia with sevoflurane to a group of pediatric 
patients following TIVA with propofol. This study found that the rates of pediatric EA 
were 46% for patients that received inhalational anesthesia with sevoflurane, and only 
9% for patients that received propofol TIVA (Key et al., 2010). Propofol has also been 
shown to produce benefits in reducing the incidence of pediatric EA when used as an 
adjunct to inhalational anesthesia with sevoflurane. In patients receiving inhalational 
anesthesia with sevoflurane, recent evidence suggests administering a 1 mg per kg bolus 
dose of propofol at the end of surgery. This method was shown to decrease the incidence 
of pediatric EA to 19.5% in patients receiving the bolus dose of propofol compared to 
46% in the group of patients to which the bolus dose was not given (Key et al., 2010).  
Prophylactic Medications 
Preoperative anxiety is considered a factor likely to contribute to the development 
of emergence agitation in pediatric patients. Several different medications are typically 
used to reduce a patient’s level of anxiety preoperatively with varying success. A detailed 



































Common pediatric preoperative drug dosages (Cote et al., 2019).   
Dexmedetomidine is an alpha 2 adrenergic receptor agonist capable of producing 
sedative, anxiolytic, and analgesic effects (Mountain et al., 2011). One of the greatest 
advantages of using dexmedetomidine is that when compared to similar sedatives, 
dexmedetomidine’s effect on respiratory function is minimal. The administration of 
dexmedetomidine is not likely to result in extreme hypoxia or hypercapnia (Cote et al., 
2019). The most common side effects of dexmedetomidine include nausea and vomiting, 
fever, and bradycardia (Mountain et al., 2011). While the preferred route of 
administration continues to be IV, dexmedetomidine can be administered via oral, IM, or 
nasal routes as well. Research suggests that when administered preoperatively in oral 
doses between 1.0 and 4.2 micrograms (mcg) per kg, dexmedetomidine demonstrated an 
ability to produce anxiolysis, decrease the severity of postoperative pain, and reduce the 
risk of developing pediatric EA (Mountain et al., 2011). Further research also suggests 
that an IV bolus of dexmedetomidine dosed at 0.3 mcg per kg five minutes before 
emergence from inhalational anesthesia with sevoflurane significantly reduced the 
severity of post-operative pain as well as reduced the incidence of pediatric EA while 
observing no adverse effects such as bronchospasm, hypotension, bradycardia, or 
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respiratory depression (Guler et al., 2005). Due to variations across several different 
studies regarding IV bolus dosing of dexmedetomidine, no clearly defined dosing 
consensus has been reached. IV bolus doses of 0.5 mcg/kg and above have been used in 
clinical studies, however, it is recommended to avoid doses greater than 0.5 mcg/kg due 
to increased incidences of side effects such as hypotension, bradycardia, and delayed 
emergence (Begum et al., 2019).  
Midazolam is a GABA receptor agonist that causes anterograde amnesia and 
anxiolysis following administration. Midazolam is the most common preoperative 
medication administered to pediatric patients. Several methods of administration 
including oral, intranasal, and IV can be used to provide a preoperative dose of 
midazolam. Typically, preoperative doses of midazolam are administered orally in doses 
between 0.25 – 0.75 mg/kg (Cote et al., 2019). The most common side effects observed 
following administration of midazolam include headache, drowsiness, amnesia, blood 
pressure changes, nausea and vomiting, and cough (Mountain et al., 2011). Some studies 
suggest a reduction in the incidence of pediatric EA has been demonstrated following the 
preoperative administration of midazolam, however, this result is believed to be the result 
of a prolonged awakening rather than a reduction in the levels of anxiety (Key et al., 
2010). Although midazolam is considered to be the most commonly administered 
preoperative anxiolytic, current evidence suggests that midazolam’s role in the 
prevention of pediatric EA is minimal at best. One study demonstrates that the 
preoperative administration of midazolam resulted in no clinically significant difference 
in pediatric post-operative behavior following general anesthesia with Sevoflurane. 
Furthermore, it has been reported that the incidence of pediatric EA in groups of children 
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receiving preoperative doses of Midazolam was nine times higher compared to groups of 
children who were not premedicated. In two separate studies, premedication with 
midazolam prior to general anesthesia with Sevoflurane produced a pediatric EA 
incidence of 38% to 60% (Key et al., 2010).  
Clonidine causes dose-related sedative and analgesic effects through an agonistic 
effect on alpha 2 receptors (Cote et al., 2019). Research suggests that the use of oral 
clonidine as a premedication in the pediatric setting reduced postoperative pain scores 
and the need for supplemental analgesics for the first twelve hours following surgery 
(Cote et al., 2019). The recommended PO dose of Clonidine for pediatrics is 4mg/kg 
(Cote et al., 2019).  Pediatric patients preoperatively medicated with Clonidine have been 
shown to demonstrate an overall reduction in the development of pediatric EA by 20% to 
30% when compared to pediatric patients preoperatively medicated with Midazolam 
(Key et al., 2010). Although several benefits are observed with the use of clonidine as a 
premedication, the need to administer the medication an hour before anesthetic induction 
is largely impractical, especially in busy outpatient settings (Cote et al., 2019).  
Existing Guidelines 
Current review and research of the literature has not yet identified any single set-
standard of guidelines for the prevention of pediatric EA. Primary risk factors thought to 
contribute to the development of pediatric EA are multifactorial. Likewise, the treatment 
recommendations for the prevention of pediatric EA require a multimodal approach. 
Currently, literature provides best-practice recommendations, however, no concrete 
guideline has been found to reduce the incidence of pediatric EA.  The proposed best-
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practice guideline aims to abridge current best-practice prevention recommendations into 
a guideline for a more strategic approach to reducing the incidence of pediatric EA. 
Summary of Available Knowledge 
Pediatric EA is characterized by acute mental disturbances consisting of 
confusion, agitation, hallucinations, and delusions. These disturbances are typically 
manifested through inconsolable crying and moaning, restlessness, involuntary 
movements, and thrashing around in the bed postoperatively (Key et al., 2010). Issues 
resulting from this common complication are known to cause decreases in patient 
satisfaction, increased postoperative complications, and increased costs of care. Risk 
factors shown to increase the incidence of developing pediatric EA following surgery 
include patients between the ages of two and five, increased anxiety preoperatively, type 
and length of surgery, use of inhalational anesthetic gases, and the patient’s post-
operative pain level (Hoch, 2019). Several efforts to mitigate the risks of developing 
pediatric EA have shown some promise, but lack a comprehensive approach to successful 
prevention. Studies suggesting the use of propofol TIVA have shown dramatic reductions 
in the incidence of pediatric EA. However, the ability to monitor appropriate anesthetic 
depth, lack of standardized drug use, and dosage, along with potential patient 
interactions, TIVA can be seen as disadvantageous and unsafe by some anesthesia 
providers when used as the sole means of achieving surgical anesthesia (Lerman & JÖhr, 
2009). Conversely, inhalational anesthesia with sevoflurane provides rapid induction and 
emergence, ease of monitoring for appropriate anesthetic depth, and a reliable and proven 
means of achieving surgical anesthesia without IV access. However, numerous studies 
have indicated that inhalational anesthesia substantially increases the risk of developing 
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pediatric EA. Throughout a review of the literature, evidence suggesting a holistic 
guideline shown to eliminate the development of pediatric EA has not been 
demonstrated. Risk factors shown to correlate with an increased incidence of developing 
pediatric EA have been shown to be multifactorial and thus a multimodal treatment 
strategy is likely warranted.  
Rationale 
Policy Expectations 
Through the proper use and implementation of policy, anesthesia providers can 
develop better strategies and techniques aimed at reducing the risks of complications, and 
improving patient outcomes. Healthcare policy development is aimed at assisting 
healthcare providers in achieving an expected standard of care through evidence-based 
research (Collins & Patel, 2009). In the area of healthcare effective policy development 
requires a multifactorial and multistep approach. A multistep approach involves 
identification of a particular issue or problem, analysis of how a particular policy will 
address the issue and impact outcomes, standardized development of the proposed policy, 
implementing the proposed policy into practice, and an evaluation of how the policy 
affected practice (Friedman, 2003). Through the appropriate use of policy, anesthesia 
providers can develop better plans and techniques to potentially improve the quality of 
patient care and reduce the occurrence of complications.  
Theoretical Framework 
A conceptual model for effecting provider behavior change was used to guide the 
development of this project. In the conceptual model, four phases identify factors 
affecting policy implementation. The four phases include exploration, decision to adopt, 
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active implementation, and sustainment (Aarons et al., 2011). The conceptual approach 
examines the roles that different variables may play during the implementation process of 
evidence-based practice guidelines. The exploration phase involves the identification of a 
problem or issue that needs a resolution or improvement. The evidence-based best-
practice guideline identifies the primary issue to be frequent occurrences of pediatric EA 
due to gaps existing between current knowledge and everyday practice. The decision to 
adopt occurs when an individual or organization experiments with new innovations 
before broad implementation is initiated. In the evidence-based best-practice guideline, 
recommendations were presented, and the panel of experts had the option to institute 
changes and/or revisions. During the active implementation phase innovation is more 
broadly implemented across platforms, and factors affecting implementation are assessed. 
Following feedback from the panel of experts, a final draft of the guideline was 
developed. Finally, in the sustainment phase factors were examined to determine the 
effectiveness of long-term implementation and maintenance (Aarons et al., 2011). 
Triple Aim 
The Institute for Healthcare Improvement introduced the Triple Aim in 2008. The 
Triple Aim focuses on three specific areas in order to improve healthcare. The areas 
included in the collaborative approach are: improving the overall health of a population, 
improving the patients’ experience of care, and reducing the cost of healthcare 
(Whittington et al., 2015). The Triple Aim requires healthcare organizations to focus on 
organizing care in order to meet the health needs of a specific population. Without 
attention to the three areas outlined in the Triple Aim, healthcare organizations could 
potentially misalign the balance between improving quality of care, and the reduction of 
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healthcare costs (Whittington et al., 2015). Through the use of Triple Aim, the evidence-
based best-practice guideline could potentially improve the patient’s experience of care, 
while also reducing health care costs. 
DNP Essentials 
The American Association of Colleges of Nursing (AACN) outlines eight 
essential Doctor of Nursing Practice (DNP) competencies deemed fundamental to the 
various roles of nurses in the advanced practice setting. All eight essentials outlined by 
the AACN were considered in the completion of this doctoral project. However, a 
particular emphasis was placed on Essentials III and VIII thought the entirety of this 
doctoral project. Essential III (Clinical Scholarship and Analytical Methods for Evidence-
Based Practice) describes the use of evidence-based research investigation to guide 
advancements in clinical practice. Essential VIII (Advanced Nursing Practice) specifies a 
foundation of competencies required for doctoral nursing practice. A complete listing of 
DNP essentials outlined by the AACN is listed in Appendix A.  
Specific Aims 
The purpose of this doctoral project was to develop an evidence-based, best-
practice guideline aimed at reducing the risk of pediatric EA following general anesthesia 
in pediatric populations. The best-practice guideline provides anesthesia providers with 
the literature reviewed, and evidence-based recommendations regarding anesthetic 
techniques and pharmacology use shown to successfully reduce the incidence of pediatric 
EA. Pediatric patients that develop pediatric EA have been shown to demonstrate low 
levels of patient satisfaction, increased incidence of postoperative complications, and 
increased costs of care associated with adverse events arising from pediatric EA. This 
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guideline was developed through the use of evidence-based research regarding best 
practice advisories on the prevention of pediatric EA. The guideline was then presented at 
The University of Southern Mississippi (USM) to a panel of experts in the field of 
anesthesia. The feedback gained from the panel of experts was used to refine areas of the 
guideline in order to provide a more strategic means of improving the quality of 
anesthetic care. The best-practice guideline has the potential to provide a means of 
improving anesthetic care outcomes and patient satisfaction at a hospital in Southeastern 
Mississippi.  
Summary 
Pediatric EA is a relatively common complication following the administration of 
general anesthesia in pediatric patients. The incidence is estimated to be anywhere from 
10% to 80%, and can likely be attributed to several different factors. Risk factors 
commonly associated with the development of pediatric EA include the age of the child, 
the child’s current level of anxiety and individual personality, the type and length of 
surgery, use of inhalational anesthetics, a rapid emergence from general anesthesia, and 
the child’s postoperative pain level (Hoch, 2019). Several of the risk factors previously 
mentioned are unable to be altered through anesthetic management. However, through 
alterations in the anesthetic technique and approach, several other risk factors could 
potentially be minimized. An evidence-based best-practice guideline for reducing the risk 
associated with the development of pediatric EA can potentially improve patient 
satisfaction, reduce recovery times in PACU, and improve the quality of anesthetic care. 
An outline detailing the process and methodology for developing the evidence-based 
best-practice guideline is described in Chapter II.  
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CHAPTER II - METHODOLOGY 
Introduction 
The requirements for the DNP project for the USM College of Nursing and 
Health Professions include meeting the AACN DNP Essentials. The evidence-based best-
practice guideline for reducing the risk of developing pediatric emergence agitation meets 
several DNP essentials outlined by the AACN, with particular focus on DNP Essential III 
and DNP Essential VIII. The evidence-based best-practice guideline was submitted to the 
USM Institutional Review Board (IRB) for review and approval. IRB approval status 
according to protocol is listed in Appendix B (IRB-20-297). Important components 
associated with pediatric EA are addressed in the evidence-based best-practice guideline 
and warrant attention. These components include: (a) current provider practices, (b) 
knowledge of evidence-based literature regarding pediatric EA, and (c) proposed benefits 
concerning the acceptance of the evidence-based best-practice guideline.  
Context 
The evidence-based best-practice guideline is targeted toward anesthesia 
providers working in a hospital in Southeastern Mississippi. The hospital’s profit election 
is a business corporation (Mississippi Secretary of State, 2014). Currently, the hospital 
employs anesthesiologists and Certified Registered Nurse Anesthetists (CRNAs) with 
varying years of clinical anesthesia experience. The hospital is also a teaching institution 
facilitating the education of medical residents, as well as student nurse anesthetists.  
Pediatric surgery cases are performed at the hospital on a weekly basis. The 
hospital has approximately 500 inpatient beds and 14 main operating rooms that are 
utilized for a variety of both adult and pediatric cases. The pediatric surgical services 
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performed at the hospital include general surgery, ear, nose, and throat surgery, and 
dental surgery. The hospital has a history of adhering to quality improvement protocols in 
the past, and the anesthesia department has been supportive of the facility’s effort. 
Currently, no formal process is in place that would affect the implementation of the 
evidence-based best-practice guideline.  
Intervention 
Recent evidence states that the incidence of pediatric EA is anywhere from 10% 
to 80% following the administration of general anesthesia (Bajwa et al., 2010). The 
purpose of the evidence-based best-practice guideline is to reduce the risk of pediatric EA 
following general anesthesia in pediatric populations. A systematic review of current 
evidence-based practice policy concerning the prevention of pediatric EA was performed. 
Information gathered from the literature was synthesized and used to guide the formation 
of the guideline. A synthesized review of the literature demonstrated a correlation 
existing between the development of pediatric EA and lower levels of patient satisfaction, 
increased postoperative complications, and increased costs of care associated with 
adverse events arising from pediatric EA. The literature also identified a gap between 
best practice recommendations and actual anesthesia provider practice (Hoch, 2019). The 
guideline provides anesthesia providers with evidence-based best-practice 
recommendations that have been shown to reduce the overall incidence of pediatric EA.  
A targeted review of evidence-based peer-reviewed literature was accomplished 
by using several online research databases: CINHAL, EBSCOhost, MEDLINE, and 
PubMed. Primary key search terms included: pediatric anesthesia, pediatric emergence 
agitation, dexmedetomidine, midazolam, clonidine, total intravenous anesthesia, volatile 
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anesthetics, and best practice recommendation. Current policies, interventions, and 
information concerning pediatric EA, anesthesia provider practice, and guideline 
development was compiled and synthesized for use in the production of the evidence-
based best-practice guideline. Following the synthesis of data, a panel of experts in the 
field of anesthesia was assembled. An email announcement to the panel of experts was 
created requesting informed consent for participation. The panel of experts included four 
CRNAs currently practicing at a hospital in Southeastern Mississippi, one pediatric 
professor at USM NAP, and the DNP project chair. The members of the panel of experts 
were chosen based on each member’s advanced knowledge in the field of anesthesia, 
particularly as it relates to the area of pediatrics. Upon assembly of the panel of experts, a 
survey was composed to obtain critical feedback from the panel. Following the 
completion of the survey, approval was sought from the DNP project chair. Once 
approval was obtained, the IRB application was submitted for review. After IRB approval 
was received, an email containing informed consent, a PowerPoint© presentation 
detailing the purposed best-practice guideline, and an anonymous link to the survey was 
sent to the panel of experts. Qualtrics© was be used as the anonymous survey tool, and 
there were no repercussions for non-participants. Data included in the PowerPoint© 
presentation was derived from a review of evidence-based literature on the prevention of 
pediatric EA and included information concerning current practice recommendations 
from the literature, alternative methods of anesthesia, and pharmacological interventions. 
The panel of experts was asked to view the presentation and offer feedback via the 
anonymous post-presentation survey. The survey examined the panel’s knowledge of 
current literature involving pediatric EA, as well as each panel member’s overall 
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willingness to adopt the proposed recommendations. Data from the survey was then 
collected and entered into a summarized table. The data collected was both quantitative 
and qualitative, and followed a mixed-methods approach. Quantitative data was 
expressed as narrative descriptions, and qualitative data was examined for similarities and 
common themes. Following the synthesis of the data, the best-practice guideline was re-
assessed and refined. Final approval was sought from the DNP project chair. Once final 
approval from the DNP project chair was obtained, the best-practice guideline was 
presented to the panel of experts working at a hospital in Southeastern Mississippi. The 
research was disseminated at USM School of Leadership and Advanced Nursing Practice 
Scholarship Day in September of 2020. All electronic data was permanently deleted from 
the computer, and the trash file was emptied. The physical data was destroyed by 
shredding. 
The evidence-based best-practice guideline is aimed at providing the panel of 
experts with recommendations supported by peer-reviewed literature which demonstrates 
that adoption of the best-practice guideline could potentially decrease the overall 
incidence of pediatric EA, potentially resulting in increased patient satisfaction, lower 
costs of care, and decreased postoperative complications.  
Survey Tool 
Data was collected from the panel of experts via an anonymous online survey. 
Qualtrics© was used as an anonymous survey tool. A link to the online survey was 
emailed to the panel following the PowerPoint presentation of the purposed best-practice 
guideline. Participation from the panel of experts was completely voluntary, and the 
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panels’ responses to the survey were kept anonymous. There were no consequences or 
repercussions for not participating. 
Due to the relatively small sample size, data obtained from the survey was not 
statistically significant. Data collected from the survey was both quantitative and 
qualitative and followed a mixed-methods approach. The quantitative data was examined 
and expressed as narrative descriptions. The qualitative data was also examined and 
common themes were reported. All data was thoroughly examined and summarized into 
table format. All information received from the voluntary participation of the panel of 
experts was kept strictly confidential and remained anonymous. Following a review of 
data obtained from the survey, final approval of the best-practice guideline was sought 
from the DNP project chair. After obtaining DNP chair approval, all information stored 
on the computer was permanently deleted, and the trash folder was emptied. 
Additionally, all information stored in paper form was destroyed via shredding.  
Ethical Considerations 
The primary ethical consideration for this project was the inability of individual 
providers to adhere to the recommended guideline following approval. If permanently 
adopted, the purposed evidence-based best-practice guideline will provide 
recommendations for reducing the incidence of pediatric EA. If some individual 
providers are unable to follow the recommendations outlined in the purposed guideline, 
two standards of pediatric anesthetic care will exist at the facility. Patients cared for by 
anesthesia providers that do not adhere to the policy could potentially be at a greater risk 




In summary, the purposed evidence-based best-practice guideline is targeted at 
reducing the overall incidence of pediatric EA, resulting in increased patient satisfaction, 
decreased risk for postoperative complications, and decreased cost of care. A panel of 
experts in the field of anesthesia was assembled and presented with a slide-show 
presentation outlining the guideline’s recommendations. An anonymous survey link was 
distributed among the panel in order to gain valuable feedback concerning the 
recommendations listed in the guideline. Panel participation was voluntary, and there 
were no repercussions for non-participants. Data gained from the survey was both 
quantitative and qualitative, and a mixed-methods approach was used for analysis. 
Information from the analysis of data was then evaluated and considered in the final draft 
of the evidence-based best-practice guideline. The final draft of the best-practice 
guideline was presented to members of the panel of experts currently working at a 






CHAPTER III  - RESULTS 
Introduction 
The effects of pediatric emergence agitation have the potential to lead to 
decreased patient and family satisfaction, higher costs of care, and increased incidences 
of postoperative complications. Currently, it is believed that the incidence of pediatric 
emergence agitation remains elevated due to a gap existing between current evidence-
based literature and actual clinical practice. The goal of the project was to develop an 
evidence-based best-practice guideline for the prevention of pediatric emergence 
agitation. The guideline was synthesized from currently available literature and 
disseminated to a panel of experts to review and provide feedback.  
Steps of the Intervention 
Following the proposed methodology, the project began with a systematic review 
of current literature pertaining to the prevention of pediatric EA. Following a review of 
the literature, a guideline for the prevention of pediatric EA was constructed. A panel of 
experts in the field of anesthesia was then assembled. The panel consisted of four 
practicing CRNAs, one pediatric professor, and the DNP chair. Once the panel of experts 
was assembled, a PowerPoint© outlining the literature contained in the guideline, along 
with an anonymous survey in order to gain feedback from the panel, was created. After 
informed consent was obtained, an email was then sent to the panel of experts containing 
the letter of informed consent, the PowerPoint©, the proposed best-practice guideline, and 
a link to the anonymous survey. The panel of experts was asked to review the material 
and offer feedback via the anonymous survey. All responses as well as the identity of the 
participants were kept completely anonymous during the entirety of the project. The 
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survey consisted of five questions pertaining to the participants' current knowledge of 
pediatric EA, willingness to adopt the best-practice guideline as well as any foreseeable 
barriers to implementation, and participants’ current practices to prevent pediatric EA. 
Additional space was also provided to allow for the participants to provide additional 
feedback by means of guideline improvement, personal practices, and additional barriers. 
Questions contained in the survey are listed in Appendix C. 
Five out of six participants from the panel of experts responded to the survey. The 
first question asked participants if the information contained in the presentation was 
informative concerning the evidence based risks associated with pediatric emergence 
agitation. Five out of five participants responded yes. The second question asked 
participants if the contents of the presentation were consistent with doctoral-level work. 
Five out of five participants responded yes. Question three asked participants if they used 
any additional measures to prevent the incidence of pediatric emergence agitation. Five 
out of five participants answered no. The fourth question asked if participants would 
consider implementing the purposed best-practice guideline into their practice. Five out 
of five participants answered yes. Question five asked participants if they foresaw any 
potential barriers to the implementation of the purposed best-practice policy. Four out of 
five participants responded no, and one out of five answered yes. The participant 
answering yes to question five listed time constraints, current hospital policies, and 
individual practitioner’s unwillingness to adopt the proposed guideline as potential 
barriers to implementation. The sixth question was qualitative and asked participants to 
provide any additional comments or recommendations to the proposed guideline. Two 
out of five participants provided additional comments concerning the quality of the 
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proposed guideline. None of the participants listed any recommendations concerning 
suggestions or improvements to the proposed guideline. Individual responses to the 
anonymous survey are listed in Appendix C. Information obtained from the survey was 
subsequently reviewed and the panel’s recommendations were considered. No alterations 
were made in the final draft of the proposed guideline. The final draft of the guideline 
was then provided via email to members of the panel of experts currently practicing at a 
hospital in Southeastern Mississippi. Research and data from the project was 
disseminated at USM School of Leadership and Advanced Nursing Practice Scholarship 
Day in September of 2020. No changes were made from the original steps outlined in 
Chapter II.  
Details of Process Measures and Outcomes 
In summary, an evidenced-based best-practice guideline for the prevention of 
pediatric EA was developed in order to decrease the incidence of pediatric EA. The 
adverse effects of pediatric EA include decreased patient satisfaction, increased costs of 
care, and higher incidences of postoperative complications. The proposed guideline 
attempts to bridge a gap between literature recommendations and anesthetic provider 
practice by providing practitioners with evidence-based interventions aimed at the 






CHAPTER IV – DISCUSSION 
Summary 
Pediatric EA is a relatively common complication following the administration of 
general anesthesia in pediatric patients. Currently, the incidence of pediatric emergence 
agitation remains elevated due to a preexisting gap between current evidence-based 
literature and the clinical practice of many anesthesia providers. The evidence-based best-
practice guideline outlined in this project attempts to provide anesthetists with current 
practices supported by literature to decrease the prevalence of pediatric emergence EA. 
Interpretation 
During the review of the literature, a comprehensive guideline outlining 
intervention to decrease the incidence of pediatric EA was not found. However, the 
literature did identify an existing gap between current recommended practices for the 
prevention of pediatric EA, and actual anesthesia provider practice. The proposed 
guideline attempts to bridge this gap by providing an evidence-based best-practice 
guideline for the prevention of pediatric EA. The proposed guideline was developed and 
a panel of experts was asked to review the information and offer feedback. The data 
provided from responses to the survey established that the panel of experts were 
accepting of the knowledge provided by current literature, and were willing to implement 
the practices contained in the guideline. Responses also established that several 
participants routinely implement interventions from the guideline into their clinical 
practice. However, the specific interventions were not made explicit by the participants. 
Implementation of the proposed guideline into clinical practice has the potential to 
decrease the prevalence of pediatric EA by providing anesthetists with evidence-based 
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knowledge concerning current practices shown to decrease incidences of pediatric EA. 
Decreasing the incidence of pediatric EA could potentially lead to higher patient 
satisfaction scores, decreased costs of care, and fewer post-operative complications.  
Limitation 
Limitations of the project are inflated by the relatively small sample of five 
respondents. However, efforts were made to optimize the quality of data collected by 
focus focusing on the selection quality for the panel of experts. Members of the panel of 
experts consisted of clinical practitioners of pediatric anesthesia, published authors of 
peer-reviewed research, and professors of nurse anesthesia. The number of questions 
contained in the survey was also limited with respect to time, in order to encourage more 
meaningful responses. Questions were targeted and to collect the data needed for the 
project. For future studies, increasing the sample size of the project could offer a wider 
range of feedback for the development of the project’s guidelines. Also, the inclusion of 
non-pharmacologic interventions and alternative methods of prevention could provide 
anesthetists with a wider range of available strategies to implement into clinical practice. 
Conclusions 
The proposed guideline was presented to a panel of experts for review. Following 
a review of the proposed guideline, the panel of experts was asked to provide feedback 
via an anonymous survey. Data gathered from participants’ responses to the survey was 
collected over a period of one week. Feedback suggested the panel of experts had a 
willingness to incorporate the guideline into clinical practice. The literature outlined in 
the project, along with data obtained from the survey was used to develop the guideline 
for the prevention of pediatric EA. The proposed guideline could be used to limit the 
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adverse effects and consequences resulting from pediatric EA. As one participant 
suggested, barriers to implementation affecting the overall sustainability of the proposed 
guideline could be influenced by factors such as the cost of medications, current provider 
practice, and time constraints. However, the proposed guideline could potentially filter 
into other contexts within the area of healthcare. The proposed guideline could be used as 
a basis to develop an Objective Structured Clinical Examination (OSCE) to be used in a 
pediatric anesthesia course. Because the proposed guideline is not specific to CRNAs and 
can apply to all anesthesia providers, hospital administration could also use information 
from the project as a means for continuing education for anesthesia providers. Further 
recommendations for the ongoing research into decreasing the incidence of pediatric EA 
should include a more comprehensive approach using alternative modalities to 
pharmacologic interventions. Additional recommendations for further research could 
include the development of an OSCE and identification of barriers to implementation. 
The advancement of knowledge and continual research into pediatric EA is vital in order 
to develop effective prevention strategies and increase the overall quality of anesthetic 






APPENDIX A – DNP Essentials 
Doctor of Nursing Essential How the Essential is Achieved 
Essential One: Scientific Underpinnings 
for Practice 
This doctoral project applied an in-depth 
review of evidenced-based literature to 
identify best practices supporting the use 
of preemptive treatments in the reduction 
of POST.  The recommendations offered 
in this project are founded upon the 
findings of scientific works.  
Essential Two: Organizational and 
Systems Leadership for Quality 
Improvement and Systems Thinking 
This doctoral project aimed to improve 
quality through policy recommendations 
to a team of experts that would review the 
recommendations, disseminate the 
information, and provide feedback that 
could lead to policy implementation. 
Essential Three: Clinical Scholarship and 
Analytical Methods for Evidence-Based 
Practice 
This doctoral project used analytical 
methods during a targeted review of the 
literature to appraise the best practices 
available to be included in the 
development of a policy recommendation 
to a team of experts. 
Essential Four: Information 
Systems/Technology and Patient Care 
Technology for the Improvement and 
Transformation of Health Care 
 
This essential is met through the 
development and implementation of a 
questionnaire to evaluate the anesthesia 
providers use and knowledge of 
preemptive treatments for POST 
Essential Five: Healthcare Policy for 
Advocacy in Health Care 
This essential is met through the 
identification of a patient care area that 
lacks a policy.  This project could foster 
the implementation of a new policy and 
improve the quality of anesthesia care.  
Essential Six: Interprofessional 
Collaboration for Improving Patient and 
Population Health Outcomes 
This doctoral project utilized professional 
communication and collaboration among 
anesthesia experts to develop and 








Essential Seven: Clinical Prevention and 
Population Health for Improving the 
Nation’s Health 
The goal of this project was to improve 
the outcomes and perioperative 
experiences of patients via the 
propagation of the evidenced-based 
practices described in this project for 
possible future implementation. 
Essential Eight: Advanced Nursing 
Practice 
This essential is met through the appraisal 
of current scientific literature, the delivery 
of a presentation regarding contemporary 
practice recommendations, and the 
collaboration of health professionals to 














APPENDIX C – Survey Questions 
Survey Questions 
 
1.) Was this presentation informative concerning the evidence-based incidence and 











3.) Do you take any additional measures to prevent the incidence of pediatric 






4.) Would you consider implementing the best-practice guideline from the presentation 





5.) Do you foresee any potential barriers to the implementation of this best practice 






6.) Please provide any additional comments regarding suggestions, improvements, or 















































































































































































APPENDIX E – Best-Practice Guideline 
 
 
BEST-PRACTICE GUIDELINE FOR REDUCING THE INCIDENCE OF PEDIATRIC 
EMERGENCE AGITATION 
 
This Guideline is aimed at preventing the incidence of pediatric emergence agitation. Review of 




 Premedication goal is to provide sedation and anxiolysis prior to induction of anesthesia. 
The three medications recommended for use are: 
 
• Dexmedetomidine – Studies suggest dexmedetomidine provides sufficient anxiolysis 
and sedation for pediatric patients prior to induction with minimal risk of respiratory 
compromise. Recommended dosing for pediatric patients prior to induction is (PO- 1-4.2 
mcg/kg) (Cote, Lerman, & Anderson, 2019).  
• Midazolam – Research demonstrates several discrepancies regarding the administration 
of midazolam and its effects on preventing the incidence of pediatric EA. Recommended 
dosing for pediatric patients prior to induction is (PO- 0.25-0.75 mg/kg) (Cote, Lerman, 
& Anderson, 2019). 
• Clonidine – Review of research shows that clonidine provides excellent sedation as well 
as prolonged analgesia following surgery. However, administration of clonidine should 
occur at least one hour prior to induction, and may not be preferred in busy settings. 





• Methods of Anesthesia – The use of inhalational anesthetics has been shown to 
significantly increase the incidence of pediatric EA. Therefore, the recommended 
anesthetic technique is to reduce the percentage of inhalational anesthetic administered. 
This should be accomplished in two ways: 
 
o TIVA following Inhalational Induction – Following anesthetic induction, 
maintenance anesthesia will be achieved via propofol TIVA (Lerman & JÖhr, 
2009).  
o TIVA/Inhalational Anesthetic Hybrid (50/50) – Following anesthetic 
inhalational induction, maintenance anesthesia will be achieved using low 
percentage inhalational anesthetic with supplemental IV bolus doses of propofol 
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